We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bioequivalence Studies Guideline Issued by EMEA
Bioequivalence Studies Guideline Issued by EMEA
February 2, 2010
Drugmakers conducting bioequivalence studies for drugs with immediate release dosage forms and systemic action should design the studies so formulation effects can be distinguished from other effects.